Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Diagnostic Techniques, Neurological
Intervention: Drug: Dexmedetomidine
Sponsors: Federal University of Minas Gerais; Santa Casa de Belo Horizonte
Recruiting - verified December 2009
Condition: Diabetic Peripheral Neuropathy
Interventions: Other: Skin biopsy; Other: Skin biopsy
Sponsors: Albany Medical College; Endo Pharmaceuticals
Recruiting - verified March 2010
Condition: Malignant Glioma
Intervention: Biological: Cancer vaccine plus immune adjuvant, plus activated killer T cells
Sponsor: TVAX Biomedical
Not yet recruiting - verified March 2010
Condition: Huntington Disease
Intervention: Drug: Dimebon (latrepirdine)
Sponsors: Medivation, Inc.; Pfizer
Active, not recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention: Drug: Rebif
Sponsor: EMD Serono
Not yet recruiting - verified March 2010
Condition: Parkinson's Disease
Intervention: Behavioral: PC based training
Sponsors: Department of Veterans Affairs; University of California, Davis
Not yet recruiting - verified March 2010
Conditions: Parkinson's Disease; MRI
Intervention: Other: 3T and 7T MR imaging
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Not yet recruiting - verified March 2010
Condition: Parkinson's Disease
Intervention:
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified March 2010
Condition: Hyperprolactinemia
Intervention: Drug: Aripiprazole
Sponsors: University of Oxford; National Institute for Health Research, United Kingdom
Not yet recruiting - verified March 2010
Condition: Migraine
Interventions: Drug: Rapimelt; Drug: [11C]AZ10419369
Sponsor: AstraZeneca
Not yet recruiting - verified March 2010
Condition: Stroke
Interventions: Other: Mission Possible; Other: delayed mission possible
Sponsors: McGill University; Canadian Stroke Network
Recruiting - verified September 2009
Condition: Epilepsy
Intervention:
Sponsors: The Epilepsy Study Consortium; Eisai Inc.; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; H. Lundbeck A/S; Pfizer; Supernus Pharmaceuticals, Inc.; UCB, Inc.
Enrolling by invitation - verified March 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Completed - verified March 2010
Condition: Vestibular Schwannoma
Intervention: Drug: Bevacizumab (Avastin)
Sponsor: Weill Medical College of Cornell University
Not yet recruiting - verified March 2010
Condition: Spinal Cord Injury
Intervention:
Sponsors: National Taiwan University Hospital; National Science Council, Taiwan
Completed - verified February 2010
Condition: Intracranial Aneurysms
Interventions: Device: Endovascular treatment of intracranial aneurysms; Device: Endovascular treatment of intracranial aneurysm with coils
Sponsor: Balt International
Recruiting - verified March 2010
Condition: Stroke
Intervention:
Sponsor: Charite University, Berlin, Germany
Recruiting - verified March 2010
Condition: Low Back Pain, Mechanical
Intervention: Other: Core Stabilization
Sponsors: Drexel University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Condition: Low Back Pain, Mechanical
Intervention: Other: Core Stabilization
Sponsor: Drexel University
Recruiting - verified March 2010
Condition: Down Syndrome
Interventions: Drug: Rivastigmine; Other: Liquid Placebo
Sponsors: Duke University; Taishoff Family Foundation
Recruiting - verified March 2010
Conditions: Anaplastic Astrocytoma; Anaplastic Ependymoma; Anaplastic Meningioma; Anaplastic Oligodendroglioma; Brain Stem Glioma; Choroid Plexus Tumor; Ependymoblastoma; Giant Cell Glioblastoma; Glioblastoma; Gliosarcoma; Grade III Meningioma; Meningeal Hemangiopericytoma; Mixed Glioma; Papillary Meningioma; Pineal Gland Astrocytoma; Pineoblastoma; Brain Tumor
Interventions: Biological: therapeutic allogeneic lymphocytes; Biological: aldesleukin; Other: laboratory biomarker analysis; Procedure: positron emission tomography
Sponsor: City of Hope Medical Center
Not yet recruiting - verified March 2010
Condition: Phenylketonuria
Intervention: Drug: Kuvan® (Sapropterin dihydrochloride)
Sponsors: Merck KGaA; Smerud Medical Research International AS
Not yet recruiting - verified March 2010
Conditions: Heart Disease; Liver Failure; Depressive Disorder; Alcoholic Neuropathy
Intervention: Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
Sponsor: Levanger Hospital
Recruiting - verified January 2010
Condition: Migraine
Interventions: Drug: Topiramate 100 mg; Drug: Topiramate 50 mg; Drug: Placebo
Sponsor: Janssen Pharmaceutical K.K.
Completed - verified March 2010
Conditions: Alzheimer Disease or Associated Disorder; Mild to Moderately Severe Dementia
Intervention: Other: Intervention of the social worker
Sponsor: Institut de Sante Publique, d'Epidemiologie et de Developpement
Recruiting - verified March 2010
Condition: Parkinson's Disease
Intervention: Device: Deep brain stimulation
Sponsor: University Hospital, Rouen
Recruiting - verified March 2010
Conditions: Parkinson's Disease; Depression
Intervention: Device: Transcranial Magnetic Stimulator
Sponsors: Beth Israel Deaconess Medical Center; Michael J. Fox Foundation for Parkinson's Research
Not yet recruiting - verified March 2010
Condition: Multiple Sclerosis
Interventions: Drug: ONO-4641; Drug: ONO-4641; Drug: ONO-4641; Drug: ONO-4641 placebo
Sponsor: Ono Pharma
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Interventions: Behavioral: CI Therapy; Behavioral: CAM treatments
Sponsor: National Multiple Sclerosis Society
Recruiting - verified March 2010
Condition: Adult Growth Hormone Deficiency
Intervention:
Sponsor: Merck KGaA
Active, not recruiting - verified March 2010
Condition: Migraine Disorders
Intervention: Drug: caffeine propranolol combination
Sponsor: Stanford University
Completed - verified March 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Alzheimer's Disease
Interventions: Drug: BMS-708163; Drug: BMS-708163; Drug: Placebo; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified March 2010
Conditions: Alzheimer's Disease; Central Nervous System Diseases; Cognition
Interventions: Drug: EVP-6124; Drug: Placebo
Sponsors: EnVivo Pharmaceuticals, Inc.; INC Research Limited
Not yet recruiting - verified February 2010
Condition: Migraine
Intervention:
Sponsors: The Cleveland Clinic; Baaken Heart Brain Institute
Recruiting - verified March 2010
Condition: Excessive Sleepiness
Interventions: Drug: Armodafinil; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified March 2010
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy
Interventions: Drug: SB-509; Other: Saline
Sponsors: Sangamo Biosciences; Juvenile Diabetes Research Foundation
Recruiting - verified March 2010
Condition: Ischemic Stroke
Intervention:
Sponsor: Charite University, Berlin, Germany
Recruiting - verified March 2010
Condition: Carpal Tunnel Syndrome
Interventions: Procedure: Open carpal tunnel release; Procedure: Open trigger finger release; Procedure: Fasciotomy; Procedure: Surgery; to restore anatomical function
Sponsor: St. Antonius Hospital
Not yet recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Chronic Low Back Pain
Interventions: Drug: Placebo; Drug: Hydrocodone bitartrate
Sponsor: Zogenix, Inc.
Active, not recruiting - verified March 2010
Condition: Neurological Disease
Intervention: Procedure: cerebral flexible endoscopy
Sponsor: Universidad Autonoma de San Luis Potosí
Recruiting - verified February 2010
Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA); National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Condition: Alzheimer Disease
Interventions: Drug: Acitretin; Drug: Placebo
Sponsors: Johannes Gutenberg University Mainz; Alzheimer Forschungsinitiative e.V. (AFI)
Not yet recruiting - verified January 2010
Condition: Multiple Sclerosis, Relapsing Remitting
Intervention: Drug: Rebif® New Formulation
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing Remitting
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing Remitting
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Conditions: Duchenne Muscular Dystrophy; Becker Muscular Dystrophy; Limb Girdle Muscular Dystrophy
Intervention:
Sponsor: Cooperative International Neuromuscular Research Group
Not yet recruiting - verified March 2010
Condition: Idiopathic Restless Legs Syndrome
Interventions: Drug: SPM 962; Drug: SPM 962; Drug: Placebo of SPM 962
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Recruiting - verified March 2010
Condition: Sleep Deprivation
Intervention: Other: Sleep Enhancement Program (SEP)
Sponsors: University of Arizona; Arizona Biomedical Research Commission (ABRC)
Not yet recruiting - verified March 2010
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: autologous bone marrow-derived stem cells
Sponsor: TCA Cellular Therapy
Recruiting - verified March 2010
Condition: Epilepsy
Intervention: Drug: Intravenous Carbamazepine
Sponsor: H. Lundbeck A/S
Completed - verified March 2010
Condition: Epilepsy
Intervention: Drug: Diazepam
Sponsors: University of Chicago; King Pharmaceuticals Research and Development
Recruiting - verified March 2010
Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Extended-release Guanfacine Hydrochloride; Other: Placebo
Sponsor: Shire Pharmaceutical Development
Not yet recruiting - verified March 2010
Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Extended-release Guanfacine Hydrochloride; Other: Placebo
Sponsor: Shire Pharmaceutical Development
Not yet recruiting - verified March 2010
Conditions: Obstructive Sleep Apnea; Obesity
Interventions: Procedure: Bariatric surgery; Device: Continuous positive airway pressure
Sponsors: Kuopio University Hospital; Helsinki University Central Hospital; Turku University Hospital; Oulu University Hospital; Vaasa Central Hospital, Vaasa, Finland; National Institute for Health and Welfare, Finland; Helsinki Sleep Clinic; Päijät-Häme Central Hospital,Lahti
Not yet recruiting - verified March 2010
Condition: Vertigo
Intervention: Other: rehabilitation maneuver
Sponsors: Day General Hospital.; Shaheed Beheshti Medical University
Completed - verified September 2009
Conditions: Cerebral Palsy; Hand Function
Intervention: Other: CIMT+HABIT
Sponsor: Alyn Pediatric & Adolecent Rehabilitation Center
Active, not recruiting - verified August 2009
Condition: Parkinson's Disease
Intervention: Procedure: Bilateral Deep Brain Stimulation
Sponsors: Department of Veterans Affairs; National Institute of Neurological Disorders and Stroke (NINDS)
Completed - verified February 2010
Conditions: Muscle Atrophy; Falls
Intervention: Other: RENEW vs TRAD
Sponsors: University of Utah; Department of Health and Human Services; National Institutes of Health (NIH); National Institute on Aging (NIA)
Recruiting - verified March 2010
Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Medication Overuse Headache
Intervention: Behavioral: Trained counselling
Sponsors: University Hospital, Akershus; Department of General Practice and Community Medicine, Oslo; Head and Neck Research Group, Lørenskog
Not yet recruiting - verified February 2010
Condition: Pain
Interventions: Drug: Ibuprofen; Drug: Placebo
Sponsor: Wyeth
Recruiting - verified March 2010
Condition: Intracranial Aneurysm
Intervention:
Sponsor: Chinese University of Hong Kong
Recruiting - verified February 2010
Conditions: Brain and Central Nervous System Tumors; Malignant Paraganglioma
Interventions: Drug: temozolomide; Drug: vorinostat; Genetic: DNA methylation analysis; Genetic: western blotting; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Condition: Subarachnoid Hemorrhage
Intervention: Drug: Simvastatin
Sponsors: Chinese University of Hong Kong; Hong Kong Government
Recruiting - verified March 2010
Conditions: Primary Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosis
Intervention: Drug: Natalizumab
Sponsors: Rigshospitalet, Denmark; Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre; Biogen Idec; GCP-unit, Copenhagen University Hospital Bispebjerg; Signifikans ApS
Recruiting - verified February 2010
Condition: Parkinson Disease
Interventions: Other: Physiotherapy Interventions; Other: Education Classes
Sponsor: Queen Elizabeth Hospital, Hong Kong
Recruiting - verified March 2010
Condition: Peripheral Vascular Diseases
Intervention:
Sponsors: Sanofi-Aventis; Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Mild Dementia
Intervention:
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Traumatic Brain Injury
Intervention:
Sponsors: University of Cincinnati; Department of Defense
Not yet recruiting - verified February 2010
Condition: Polyneuropathy
Intervention: Drug: Cilostazol
Sponsor: Otsuka Pharmaceutical, Inc., Philippines
Completed - verified February 2010
Condition: Alzheimer's Disease
Interventions: Drug: Interferon beta-1a; Drug: Placebo
Sponsor: Merck KGaA
Completed - verified March 2010
Condition: Multiple Sclerosis
Intervention: Drug: Betaseron (Interferon beta-1b, BAY86-5046)
Sponsor: Bayer
Not yet recruiting - verified March 2010
Condition: Ataxia Telangiectasia
Interventions: Biological: Prevenar® (7-valent pneumococcal conjugate vaccine); Biological: Pneumovax® (pneumococcal polysaccharide vaccine)
Sponsor: Sheba Medical Center
Not yet recruiting - verified February 2010
Condition: Pain, Postoperative
Interventions: Drug: continuous ropivacaine preperitoneal infusion; Drug: intravenous lidocaine infusion; Drug: parenteral analgesia combining acetaminophen and morphine; Drug: NaCl
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2010
Conditions: Discogenic Pain; Low Back Pain
Interventions: Procedure: Functional anesthetic discography; Procedure: Provocative Discography
Sponsors: Northwestern University; Medtronic Spine LLC
Recruiting - verified February 2010
Condition: Gaucher Disease
Interventions: Drug: Genz-112638; Drug: Genz-112638
Sponsor: Genzyme
Not yet recruiting - verified January 2010
Conditions: Traumatic Brain Injury; Post-Traumatic Stress Disorder
Intervention:
Sponsors: St. Louis University; Department of Defense
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Rebif (Interferon beta-1a)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Obstructive Sleep Apnea
Intervention:
Sponsor: Covidien
Recruiting - verified February 2010
Conditions: Cryptococcal Meningitis; HIV Infections; AIDS
Interventions: Other: Early HIV Therapy Initiation; Other: Standard HIV Therapy Initiation
Sponsors: University of Minnesota - Clinical and Translational Science Institute; Makerere University; Mbarara University of Science and Technology; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Condition: Parkinson Disease
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified December 2009
Condition: Fibromyalgia
Interventions: Drug: Placebo; Drug: Milnacipran
Sponsors: Forest Laboratories; Cypress Bioscience, Inc.
Recruiting - verified February 2010
Conditions: Obsessive Compulsive Disorder; Body Dysmorphic Disorder; Tourette Syndrome; Trichotillomania; Panic Disorder; Social Phobia; Generalized Anxiety Disorder; Depression; Post-Traumatic Stress Disorder; Attention Deficit Hyperactivity Disorder; Eating Disorder
Intervention: Behavioral: Cognitive behavioral therapy (CBT)
Sponsor: Massachusetts General Hospital
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention: Other: Strength training and treadmill training
Sponsors: St. Olavs Hospital; Sør-Trøndelag University College; Samarbeidsorganet Helse Midt-Norge HiST
Recruiting - verified December 2009
Conditions: Multiple Sclerosis; Optic Neuritis; Minocycline
Intervention: Drug: Minocycline
Sponsors: University of Calgary; Neuroscience Canada
Recruiting - verified February 2010
Condition: Radiculopathy
Intervention: Drug: Kenalog and Sensorcaine
Sponsor: Saint John Regional Hospital
Not yet recruiting - verified January 2010
Conditions: Infantile Spasms; Adult Refractory Complex Partial Seizures
Intervention:
Sponsor: H. Lundbeck A/S
Enrolling by invitation - verified February 2010
Conditions: Migraine; Headache; Pediatric
Intervention: Drug: Normal saline
Sponsor: University of Alberta
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention: Drug: Interferon-β-1a
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: TEAMS (Training Attention Executive and Motor Skills)
Sponsor: Queens College, The City University of New York
Recruiting - verified February 2010
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: OPDC-34712 plus stimulant therapy; Drug: Placebo plus stimulant therapy
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Not yet recruiting - verified February 2010
Condition: Neuromuscular Disease
Interventions: Drug: A0001 (alpha-tocopherolquinone); Drug: Placebo
Sponsor: Penwest Pharmaceuticals Co.
Recruiting - verified February 2010
Condition: Hypertension
Intervention: Drug: Enalapril maleate (10 mg) + nitrendipine (20 mg)
Sponsor: Merck KGaA
Completed - verified February 2010
Condition: Age Related Macular Degeneration
Intervention:
Sponsor: Notal Vision Ltd
Recruiting - verified February 2010
Conditions: Alzheimer's Disease; Amnestic Mild Cognitive Impairment
Intervention: Drug: Posiphen® tartrate capsules
Sponsor: QR Pharma Inc.
Recruiting - verified February 2010
Conditions: Spinal Cord Injury; Urinary Tract Infection; Rehabilitation
Intervention: Dietary Supplement: Cranberry capsules
Sponsor: Uppsala University
Not yet recruiting - verified January 2010
Conditions: PTSD; TBI (Traumatic Brain Injury)
Intervention:
Sponsors: Department of Veterans Affairs; University of California, Berkeley
Not yet recruiting - verified February 2010
Condition: Parkinson's Disease
Interventions: Drug: Amantadine; Drug: Placebo
Sponsors: Rush University Medical Center; Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified February 2010
Conditions: Chronic Fatigue Syndrome; Cognitive Impairments
Interventions: Drug: Lisdexamfetamine Dimesylate; Drug: Placebo Comparator: Sugar pill
Sponsors: Rochester Center for Behavioral Medicine; Shire Pharmaceutical Development
Recruiting - verified February 2010
Conditions: Apoplexy; Femoral Neck Fracture; Myocardial Infarction; Subarachnoid Hemorrhage; Polytrauma
Intervention:
Sponsors: Ruhr University of Bochum; Workers' Samaritan Federation Germany
Completed - verified February 2010
Condition: Stroke, Acute
Intervention: Drug: Simvastatin
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Recruiting - verified February 2010
Condition: Chronic Migraine
Interventions: Drug: Botox; Drug: Placebo
Sponsors: Cady, Roger, M.D.; Allergan
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: natalizumab; Drug: interferon beta 1-a; Drug: methylprednisolone; Other: IV placebo; Drug: glatiramer acetate
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Migraine
Interventions: Drug: Naproxen; Drug: Sumatriptan; Behavioral: Migraine education; Behavioral: Reenforcement of diagnosis; Other: Typical care
Sponsor: Montefiore Medical Center
Recruiting - verified February 2010
Condition: Cerebral Stroke
Intervention: Device: Anklebot (Ankle Robot)
Sponsors: Department of Veterans Affairs; University of Maryland, Baltimore, School of Medicine
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention: Drug: Tysabri
Sponsors: University of Chicago; Biogen Idec
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis, Relapsing Forms
Intervention:
Sponsors: Rocky Mountain Multiple Sclerosis Clinic; Biogen Idec
Enrolling by invitation - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010
Conditions: Obstructive Sleep Apnea; Excessive Daytime Sleepiness
Interventions: Drug: BF2.649; Drug: Placebo
Sponsor: Bioprojet
Not yet recruiting - verified February 2010
Conditions: Obstructive Sleep Apnea; Excessive Daytime Sleepiness
Interventions: Drug: BF2.649; Drug: modafinil; Drug: Placebo
Sponsor: Bioprojet
Not yet recruiting - verified February 2010
Conditions: Cerebrovascular Accident; Hemiparesis; Hemiplegia
Interventions: Behavioral: HAS Training; Behavioral: HAT training; Behavioral: Bimanual Training
Sponsor: New Jersey Institute of Technology
Recruiting - verified February 2010
Condition: Insomnia
Intervention: Behavioral: cognitive behavioral therapy for insomnia (CBT-I)
Sponsor: University of Illinois
Recruiting - verified February 2010
Condition: Minimal Hepatic Encephalopathy
Interventions: Drug: Rifaximin; Drug: rifaximin
Sponsors: Hunter Holmes Mcguire Veteran Affairs Medical Center; Salix Pharmaceuticals
Recruiting - verified February 2010
Conditions: Acute Brain Injuries; TBI (Traumatic Brain Injury); Intracranial Hemorrhages
Intervention: Other: There are no interventions in this study
Sponsor: Johannes Gutenberg University Mainz
Completed - verified March 2001
Condition: Cerebrovascular Accident
Interventions: Behavioral: Aerobic exercise group; Behavioral: Control group; Behavioral: Follow-up first aerobic exercise group; Behavioral: Follow-up control group; Behavioral: Follow-up second aerobic exercise group
Sponsors: University College of Antwerp; Universiteit Antwerpen; Katholieke Universiteit Leuven; University Hospital, Antwerp
Active, not recruiting - verified February 2010
Condition: Stroke
Intervention: Other: No intervention in this study
Sponsor: Johannes Gutenberg University Mainz
Recruiting - verified August 2008
Condition: Cerebral Palsy
Interventions: Biological: Cord Blood Infusion; Biological: Intravenous Sham
Sponsor: Medical College of Georgia
Recruiting - verified February 2010
Conditions: Sleep Apnea Syndrome; Polygraphy; Community Acquired Pneumonia; Infections
Intervention: Device: abbreviated polysomnography
Sponsor: Hospital Universitario San Juan de Alicante
Completed - verified February 2006
Conditions: Ischemic Stroke; Transient Ischemic Attack
Intervention: Other: Stroke prevention care program
Sponsors: Sepulveda Research Corporation; National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting - verified February 2010
Conditions: Epilepsy; Tuberous Sclerosis Complex
Intervention: Drug: Everolimus
Sponsors: Children's Hospital Medical Center, Cincinnati; Novartis
Not yet recruiting - verified February 2010
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Lisdexamfetamine Dimesylate-LDX
Sponsors: New York University School of Medicine; Shire Pharmaceutical Development
Completed - verified February 2010
Condition: Becker Muscular Dystrophy
Interventions: Drug: Tadalafil; Drug: Placebo
Sponsors: Cedars-Sinai Medical Center; Muscular Dystrophy Association
Recruiting - verified March 2010
Condition: Low Back Pain
Interventions: Other: educational booklet; Other: IRENA; Other: RÜCKGEWINN
Sponsors: University of Erlangen-Nürnberg Medical School; German Federal Pension Fund
Recruiting - verified February 2010
Conditions: Akathisia; Nausea
Intervention: Drug: metoclopramide 10 mg
Sponsor: Pamukkale University
Completed - verified March 2007
Conditions: Breast Cancer; Fatigue; Insomnia
Intervention: Procedure: Therapeutic Massage
Sponsors: Floyd Memorial Hospital and Health Services; Indiana University
Not yet recruiting - verified February 2010
Condition: Obstructive Sleep Apnea
Intervention:
Sponsor: Doctor's Directive Strategies Inc.
Active, not recruiting - verified December 2009
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Guanfacine Extended Release; Drug: Placebo
Sponsors: The University of Texas Health Science Center at San Antonio; Shire Pharmaceutical Development
Not yet recruiting - verified February 2010
Condition: Growth Hormone Deficiency
Intervention: Behavioral: No treatment given
Sponsor: Novo Nordisk
Not yet recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: PT003 MDI; Drug: PT005 MDI; Drug: Placebo MDI; Drug: Tiotropium bromide 18 μg (Spiriva Handihaler®); Drug: Formoterol Fumarate 12 μg (Foradil® Aerolizer®); Drug: PT001 MDI
Sponsor: Pearl Therapeutics, Inc.
Recruiting - verified March 2010
Condition: Brain Dead
Intervention: Other: Transcranial doppler
Sponsor: Institut d'Anesthesiologie des Alpes Maritimes
Recruiting - verified February 2010
Conditions: Neglect; Dysphagia
Interventions: Drug: Modafinil; Drug: Placebo
Sponsors: University of Arkansas; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified March 2010
Condition: Anorexia Nervosa
Interventions: Drug: aripiprazole; Drug: placebo
Sponsor: Hospital Clinic of Barcelona
Not yet recruiting - verified March 2010
Condition: Primary Sjögren Syndrome
Intervention: Biological: blood sample
Sponsor: University Hospital, Limoges
Recruiting - verified March 2010
Condition: Cardiovascular Disease
Interventions: Drug: Active Clonidine; Drug: Placebo Clonidine; Drug: Active ASA; Drug: Placebo ASA
Sponsor: Hamilton Health Sciences
Not yet recruiting - verified March 2010
Condition: Systemic Lupus Erythematosus
Intervention:
Sponsors: North Shore Long Island Jewish Health System; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Relapsed and Bortezomib Refractory Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma
Intervention: Drug: panobinostat, bortezomib, dexamethasone
Sponsor: Novartis
Not yet recruiting - verified March 2010
Condition: Tobacco Dependence
Interventions: Drug: Experimental Nicotine; Drug: NiQuitinTM Nicotine Lozenge; Drug: Nicorette® Nicotine Gum
Sponsor: Johnson & Johnson Consumer & Personal Products Worldwide
Completed - verified March 2010
Condition: Tobacco Dependence
Interventions: Drug: Experimental Nicotine; Drug: Nicotine Lozenge; Drug: Nicotine gum
Sponsor: Johnson & Johnson Consumer & Personal Products Worldwide
Completed - verified March 2010
Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified March 2010
Condition: Viral Infections of the Upper Respiratory Tract
Interventions: Drug: Dexchlorpheniramine, pseudoephedrine, guaifenesin; Drug: Dexchlorpheniramine
Sponsor: Mantecorp Industria Quimica e Farmaceutica Ltd.
Not yet recruiting - verified March 2010
Conditions: Small-Fiber Neuropathy; Chronic Kidney Disease
Intervention: Other: Skin biopsy
Sponsor: National Taiwan University Hospital
Recruiting - verified February 2010
Condition: Multiple Myeloma
Intervention: Drug: velcade
Sponsor: PETHEMA Foundation
Not yet recruiting - verified March 2010
Condition: Relapsed Multiple Myeloma
Interventions: Drug: Dexamethasone; Drug: Lenalidomide; Drug: Carfilzomib
Sponsor: Onyx Therapeutics, Inc.
Not yet recruiting - verified March 2010
Conditions: Autism; Asperger's Disorder; Pervasive Developmental Disorder NOS
Interventions: Drug: memantine; Drug: Placebo
Sponsors: Johns Hopkins University; Forest Laboratories
Enrolling by invitation - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium and Formoterol; Drug: Placebo; Drug: Formoterol; Drug: Aclidinium; Drug: Aclidinium and Formoterol
Sponsors: Almirall, S.A.; Forest Laboratories
Recruiting - verified March 2010
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib; Drug: dexamethasone; Drug: melphalan
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Conditions: Sarcopenia; Osteoporosis; Aging
Interventions: Drug: Acetaminophen; Drug: Ibuprofen; Behavioral: high intensity progressive resistance exercise training; Drug: placebo
Sponsor: University of Colorado, Denver
Active, not recruiting - verified March 2010
Conditions: Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
Interventions: Drug: vorinostat; Drug: ixabepilone
Sponsor: City of Hope Medical Center
Not yet recruiting - verified March 2010
Condition: Oral Lichen Planus
Interventions: Drug: Minocycline; Drug: Dexamethasone
Sponsor: Sheba Medical Center
Not yet recruiting - verified March 2010
Condition: Bipolar Disorder
Interventions: Drug: Depakote; Drug: Lithium
Sponsors: Lawson, William B., M.D., PhD, DFAPA; Abbott
Withdrawn - verified February 2010
Condition: Waldenstrom's Macroglobulinemia
Interventions: Drug: pomalidomide; Drug: dexamethasone; Drug: rituximab
Sponsors: Dana-Farber Cancer Institute; Celgene Corporation
Not yet recruiting - verified March 2010
Condition: Cardiac Arrest
Interventions: Drug: Use of prophylactic anticonvulsants (valproate, clonazepam); Drug: Control group
Sponsor: Samsung Medical Center
Not yet recruiting - verified March 2010
Condition: Vitiligo
Interventions: Drug: topical tacrolimus treatment; Drug: topical pimecrolimus treatment; Drug: local mometasone furoate treatment; Drug: vaseline treatment
Sponsor: University Hospital, Ghent
Recruiting - verified March 2010
Condition: Schizophrenia
Interventions: Drug: MS14; Drug: Risperidone
Sponsor: Farzan Institute
Recruiting - verified February 2010
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib; Drug: cyclophosphamide; Drug: dexamethasone; Drug: pegylated liposomal doxorubicin hydrochloride
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: Indacaterol dose; Drug: Placebo; Drug: Salmeterol
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Asthma
Intervention: Drug: paracetamol
Sponsor: Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified February 2010
Condition: Schizophrenia
Interventions: Drug: paliperidone palmitate injection; Drug: oral antipsychotics
Sponsor: Janssen-Cilag International NV
Not yet recruiting - verified March 2010
Condition: Major Depressive Disorder
Intervention: Drug: fluoxetine
Sponsor: Kaohsiung Kai-Suan Psychiatric Hospital
Completed - verified February 2010
Condition: Schizophrenia Patients
Intervention: Drug: Lurasidone HCl
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified March 2010
Conditions: Depressive Disorder; Cancer
Interventions: Drug: Regular bupropion use; Drug: Regular SSRI (Selective serotonin reuptake inhibitors) use; Drug: Regular use of any other antidepressant; Drug: Regular TCA (Tricyclic antidepressants) use
Sponsor: GlaxoSmithKline
Active, not recruiting - verified February 2010
Condition: Schizophrenia
Intervention: Drug: Lurasidone HCl
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified February 2010
Condition: Intubation, Gastrointestinal
Interventions: Drug: Lignocaine; Drug: Placebo
Sponsor: Queensland Children's Medical Research Institute
Not yet recruiting - verified February 2010
Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified February 2010
Condition: Coxarthrosis
Intervention: Drug: Corticosterone
Sponsor: University Hospital Pellenberg
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Abbott
Recruiting - verified March 2010
Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified February 2010
Conditions: Hypertension, Pregnancy-Induced; Hypertension
Interventions: Drug: Labetalol or Methyldopa or Nifedipine or Hydralazine; Drug: Labetalol or Methyldopa or Nifedipine or Hydralazine
Sponsors: Hillel Yaffe Medical Center; University of British Columbia; CHIPS Trial Clinical Coordinating Center
Not yet recruiting - verified March 2010
Conditions: Alcohol Dependence; Problematic Drinking; Hazardous Drinking; Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation); Drug: Placebo
Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo; Drug: Tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: Intermittent, sub-chronic and chronic Flixonase use; Drug: Intermittent, sub-chronic and chronic use of intranasal steroids other than Flixonase
Sponsor: GlaxoSmithKline
Active, not recruiting - verified February 2010
Condition: Hypertension
Intervention: Drug: Lodoz (Combination of bisoprolol and hydrochlorothiazide)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Influenza
Interventions: Drug: Chloroquine; Drug: Placebo
Sponsor: National University Hospital, Singapore
Active, not recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: Meptin® Swinghaler; Drug: Ventolin® MDI
Sponsor: Taiwan Otsuka Pharm. Co., Ltd
Recruiting - verified February 2010
Condition: Hypotension After Reperfusion in Liver Transplantation
Interventions: Drug: Phenylephrine; Drug: epinephrine; Drug: placebo control
Sponsor: Seoul National University Hospital
Not yet recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Bisoprolol; Drug: Atenolol
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Ankylosing Spondylitis
Intervention:
Sponsor: Merck
Active, not recruiting - verified February 2010
Conditions: Major Depressive Disorder; Personality Disorder
Interventions: Behavioral: Mindfulness-based Behavioural Therapy (MIBT); Behavioral: PT (psychodynamic therapy)
Sponsor: Psychiatry Roskilde
Recruiting - verified February 2010
Condition: Depression
Intervention: Drug: Buprenorphine
Sponsors: University of Pittsburgh; National Institutes of Health (NIH); Reckitt Benckiser Inc.; National Center for Research Resources (NCRR)
Not yet recruiting - verified February 2010
Condition: Alcoholism
Interventions: Drug: Baclofen; Drug: Cyproheptadine
Sponsor: Brown University
Recruiting - verified February 2010
Condition: Respiratory Failure
Interventions: Drug: dexmedetomidine; Procedure: Vital signs; Procedure: blood sampling
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Major Depressive Disorder
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsor: Eli Lilly and Company
Not yet recruiting - verified February 2010
Condition: Liver Cancer
Interventions: Drug: sorafenib tosylate; Drug: vorinostat
Sponsors: Virginia Commonwealth University; Massey Cancer Center
Not yet recruiting - verified March 2010
Condition: Allergic Rhinitis
Interventions: Drug: Fluticasone Furoate Nasal Spray; Drug: Olopatadine Nasal Spray; Drug: Saline Nasal Spray
Sponsor: ORA, Inc.
Not yet recruiting - verified February 2010
Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing
Intervention: Drug: TNF blockers (infliximab, adalimumab, etanercept)
Sponsor: University of Sao Paulo
Recruiting - verified January 2010
Condition: Coronary Artery Disease
Interventions: Drug: Placebo (12-Month Arm); Drug: Prasugrel and Clopidogrel (30-Month Arm); Drug: ASA
Sponsor: Medtronic Vascular
Not yet recruiting - verified February 2010
Condition: Chronic Alcoholic Pancreatitis
Interventions: Drug: Precedex; Drug: sodium chlorid 0,9%
Sponsor: Helsinki University Central Hospital
Not yet recruiting - verified August 2009
Condition: Multiple Myeloma de Novo Treatment
Interventions: Drug: Thalidomide, Dexamethasone; Drug: Vincristin , Adriamycin, Dexamethasone = VAD; Drug: Thalidomide, melphalan, endoxan, dexamethasone (MCDex-Thal); Drug: melphalan, endoxan, dexamethasone (MCDex); Drug: Thalidomide, Dexamethasone
Sponsors: University Hospital, Caen; Laphal
Completed - verified February 2010
Condition: Primary Systemic Amyloidosis
Interventions: Drug: bortezomib; Drug: cyclophosphamide; Drug: dexamethasone
Sponsor: Mayo Clinic
Not yet recruiting - verified February 2010
Condition: Post-surgical Dental Pain
Interventions: Drug: Placebo; Drug: Paracetamol 1000 mg; Drug: Paracetamol 650 mg
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Uremic Pruritus
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsor: Shaare Zedek Medical Center
Not yet recruiting - verified February 2010
Conditions: Fever; Analgesia
Intervention: Drug: Paracetamol
Sponsor: University of Athens
Completed - verified February 2010
Condition: Prevention
Interventions: Drug: D961H; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified February 2010
Condition: Atelectasis
Interventions: Other: Spontaneous Breathing; Other: Pressure Controlled Ventilation; Other: Pressure Support Ventilation
Sponsor: Dresden University of Technology
Not yet recruiting - verified February 2010
Conditions: Hypertension; Hypotension; Tachycardia; Bradycardia; Arrhythmia
Interventions: Drug: Epinephrin (Intranasal injection); Drug: Epinephrin (Topical administration)
Sponsor: Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Device: placebo; Drug: Fluticasone Furoate (FF)/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Pregnancy
Intervention: Drug: duloxetine
Sponsors: Eli Lilly and Company; Kendle International
Recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: QAX028; Drug: QAX028; Drug: Tiotropium; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - verified February 2010
Condition: Vivax Malaria
Interventions: Drug: Artesunate; Drug: Chloroquine; Drug: Chloroquine/Primaquine
Sponsors: University of Oxford; Mahidol University
Not yet recruiting - verified February 2010
Condition: Exercise Induced Asthma
Interventions: Drug: Budesonide/Formoterol; Drug: Budesonide
Sponsors: Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: CHF 5188 pMDI; Drug: Budesonide extrafine pMDI; Drug: Seretide(r) Evohaler(r)
Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting - verified February 2010
Condition: Heart Failure, Congestive
Intervention: Drug: Bisoprolol
Sponsor: Merck KGaA
Recruiting - verified February 2010
Conditions: Pain; Obesity; Surgery
Interventions: Drug: Placebo; Drug: (study group) will receive a bilateral TAP block using 30 cc of 0.5% ropivacaine on each side.
Sponsor: Northwestern University
Recruiting - verified February 2010
Condition: Post-surgical Dental Pain
Interventions: Drug: Placebo; Drug: Paracetamol 1000 mg; Drug: Paracetamol 500 mg
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin; Drug: Ibuprofen
Sponsor: Shaare Zedek Medical Center
Not yet recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: AZD6765; Drug: midazolam
Sponsor: AstraZeneca
Recruiting - verified February 2010
Condition: Schizophrenia
Intervention: Drug: Quetiapine XR
Sponsors: Hannover Medical School; Hannover Clinical Trial Center GmbH; AstraZeneca
Recruiting - verified February 2010
Condition: Pulmonary Hypertension
Intervention: Drug: Dexmedetomidine
Sponsor: Children's Hospital of Philadelphia
Not yet recruiting - verified February 2010
Condition: Drug Dependence
Intervention: Drug: 2-4 of the drugs listed below
Sponsors: University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Condition: Pruritus
Interventions: Drug: Naloxone; Drug: Saline/Morphine
Sponsor: University of British Columbia
Not yet recruiting - verified February 2010
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
